Trademark: 79047879
Word

Status
Registered
Status Code
706
Status Date
Monday, February 24, 2020
Serial Number
79047879
Registration Number
3744800
Registration Date
Tuesday, February 2, 2010
Mark Type
2000
Filing Date
Tuesday, September 4, 2007
Published for Opposition
Tuesday, November 17, 2009

Trademark Owner History
Menarini Silicon Biosystems S.p.A. - Original Registrant
SILICON BIOSYSTEMS S.p.A. - Owner At Publication

Classifications
9 [ Computer and computer software for collection, organization, analysis, integration and communication of scientific records, namely, transmission, display, and archival of scientific records; ] equipment for carrying out biological clinical, physical and chemical-physical analysis, namely, cytometers and analyzers providing cell and particle analysis, detection, sorting or counting, sensor chips, cell and particle impedence, detectors, optical detector arrays, for scientific, laboratory and general research uses; [ electroporation instruments, cell fusion instruments, and microbead-functionalization instruments for the synthesis of chemical and biological substances; equipments and disposables, for scientific, laboratory, and general research uses, namely, plate reader, ] cell counter, [ spectrofluorometer, spectrometer, spectrum analyzer, interferometers, ] lasers, light emitting diodes, optical lenses, optical filters, optoelectronics, prisms, refractometers, hematology automated analyzer, flow cytometer, [ coagulometers, routine biochemistry analyzer, test tubes that can be used in chemical analyses, biological analyses or patterning for scientific or laboratory use; ] equipment for cell manipulation, namely, precision instruments for manipulation and positioning of microscopics; biochips and biosensors, namely, dielectrophoretic actuators, integrated optical and/or impedence sensor arrays, cell counting chips; electric and electronic memory units, namely, semi-conductor memory units for storing information such as images and analysis results data; magnetic and optical memory units, namely, hard-disks, DCD, CD, or storage information such as images and analysis results data; clinical, laboratory and analytical instruments, namely, [ cytometers, ] cell sorters, microscopes, cell separation devices; microfluidic devices, namely, programmable microelectronic electrode arrays for cell manipulation, micro-machined chips for cell separation and processing, for scientific, laboratory and general research uses; instrumental components and laboratory complementing instruments, namely, computer hardware and peripherals; laboratory disposable materials, namely, plastic or glass chips having multi-well arrays and silicon chips for scientific use, non-medical diagnostic research [, and therapy, namely, cell-therapy ]
1 Chemical, biochemical, biological preparations, namely, antibodies, proteins, [ serum, ] enzymes and biotechnological preparations, namely, biotechnology formed enzymes or genes, nucleic acid probes, primers for polymerase chain reaction (PCR) amplification, preparations for scientific purposes; chemical biochemical, biological and biotechnological products, namely, suspension buffers, fluorescent dyes, staining and other reagents, cleaning solutions, [ sterilizing solutions, ] antibodies, biologically active proteins, peptides and nucleic acids for clinical or pre-clinical research use, reagents and assay kits comprised of reagents, chemicals and buffers for scientific use; chemical, biochemical, biological and biotechnical compounds for scientific use to fix cells, to permeabilize cells, to identify cells by fluorescent detection of by modification of optical properties, to modify cells and particle dielectrophoretic mobility, as suspension buffers for dielectrophoresis (DEP) manipulation, as culture media, and to separate cells; chemical, biochemical, biological and biotechnological products and preparations, namely, cell lines, antibodies, proteins, peptides, [ growth factors, ] buffers, substrates, [ DNA probes for scientific use, namely, for the identification of primary compounds with biological activity, namely, visibility, proliferation, apoptosis, lysis, phagocytosis, cell differentiation, transfection, gene-silencing, gene expression, protein production, translocation, secretion, other compounds uptake or release; ] chemical, biochemical, biological and biotechnological products, namely, suspension buffers, fluorescent dyes, staining and other reagents, [ cleaning solutions, sterilizing solutions, ] antibodies, biologically active proteins, peptides and nucleic acids, primers, reagents, and assay kits comprised of reagents, chemicals and buffers for laboratory analysis which is not for medical or veterinary use, products, namely, suspension buffers, fluorescent dyes, staining and other reagents, cleaning solutions, sterilizing solutions, antibodies, biologically active proteins, peptides and nucleic acids, primers, reagents and assay kits comprised of reagents, chemicals and buffers for diagnosis which is not for medical or veterinary use; chemical reagents not for medical or veterinary purposes; diagnostic reagents for clinical or medical laboratory use
10 Equipment and instruments for blood testing, blood analysis, and genetic analysis in the field of reproductive health, oncology, cell sorting and manipulation devices for use in the medical, diagnostic, pharmaceutical [ or veterinary fields ]; equipment and instruments for stem cells isolation and processing, in regenerative medicine, namely, microfabricated cell-sorter chips and control equipment; apparatus for diagnosing human genetic disease, tumor, [ infection disease, by the application of biochip techniques, namely, microfabricated cell-sorter chips and control equipment; ] components and accessories for the aforesaid equipment and instruments, [ namely, filters for blood and blood components, ] biochips for cell sorting, biochips for sample preparation
The mark consists of a square with rounded corners to which a circular figure is superimposed, on the higher side on the left; the portion where both figures are superimposed is a colour tone darker than the same figures.
Color is not claimed as a feature of the mark.

Trademark Events
Mar 15, 2023
Teas Change Of Correspondence Received
Mar 15, 2023
Teas Change Of Domestic Representatives Address
Mar 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 3, 2021
Partial Invalidation Processed By The Ib
Nov 13, 2020
Partial Invalidation Of Reg Ext Protection Sent To Ib
Nov 13, 2020
Invalidation Processed
Oct 24, 2020
Partial Invalidation Of Reg Ext Protection Created
Feb 24, 2020
Notice Of Acceptance Of Sec. 71 - E-Mailed
Feb 24, 2020
Registered-Sec.71 Accepted
Jan 28, 2020
Teas Section 71 Received
Feb 4, 2019
Teas Change Of Correspondence Received
Feb 2, 2019
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Nov 23, 2017
International Registration Renewed
Oct 26, 2017
Change Of Name/Address Rec'd From Ib
Sep 17, 2015
New Representative At Ib Received
Apr 29, 2015
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
Apr 29, 2015
Registered - Sec. 71 Accepted & Sec. 15 Ack.
Apr 29, 2015
Case Assigned To Post Registration Paralegal
Apr 16, 2015
Teas Section 71 & 15 Received
Feb 5, 2013
Final Decision Transaction Processed By Ib
May 25, 2010
Final Disposition Notice Sent To Ib
May 25, 2010
Final Disposition Processed
May 2, 2010
Final Disposition Notice Created, To Be Sent To Ib
Feb 2, 2010
Registered-Principal Register
Nov 17, 2009
Official Gazette Publication Confirmation E-Mailed
Nov 17, 2009
Published For Opposition
Oct 13, 2009
Law Office Publication Review Completed
Oct 5, 2009
Approved For Pub - Principal Register
Sep 8, 2009
Ex Parte Appeal-Instituted
Sep 8, 2009
Jurisdiction Restored To Examining Attorney
Sep 4, 2009
Exparte Appeal Received At Ttab
Sep 1, 2009
Paper Received
Sep 3, 2009
Amendment From Applicant Entered
Sep 3, 2009
Correspondence Received In Law Office
Sep 1, 2009
Paper Received
Jul 3, 2009
Notification Of Possible Opposition - Processed By Ib
Jun 18, 2009
Notification Of Possible Opposition Sent To Ib
Jun 18, 2009
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 17, 2009
Notification Of Final Refusal Emailed
Apr 17, 2009
Final Refusal E-Mailed
Apr 17, 2009
Final Refusal Written
Mar 3, 2009
Amendment From Applicant Entered
Mar 3, 2009
Correspondence Received In Law Office
Feb 27, 2009
Paper Received
Aug 29, 2008
Notification Of Non-Final Action E-Mailed
Aug 29, 2008
Non-Final Action E-Mailed
Aug 29, 2008
Non-Final Action Written
Aug 26, 2008
Previous Allowance Count Withdrawn
Aug 25, 2008
Withdrawn From Pub - Og Review Query
Aug 14, 2008
Law Office Publication Review Completed
Aug 14, 2008
Approved For Pub - Principal Register
Aug 5, 2008
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2008
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 25, 2008
Amendment From Applicant Entered
Jul 25, 2008
Correspondence Received In Law Office
Jul 25, 2008
Assigned To Lie
Jul 24, 2008
Paper Received
Feb 15, 2008
Refusal Processed By Ib
Jan 30, 2008
Non-Final Action Mailed - Refusal Sent To Ib
Jan 30, 2008
Refusal Processed By Mpu
Jan 30, 2008
Non-Final Action (Ib Refusal) Prepared For Review
Jan 29, 2008
Non-Final Action Written
Jan 18, 2008
Assigned To Examiner
Jan 18, 2008
New Application Entered
Jan 17, 2008
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24